1.
Jeffrey D. Lebensburger, Tamara I. Pestina, Russell E. Ware, Kelli L. Boyd, Derek A. Persons. Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model. haematol [Internet]. 2010Aug.31 [cited 2024Nov.25];95(9):1599-603. Available from: https://haematologica.org/article/view/5727